This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Luann L. Crussell-Porter, PharmD; Joseph P. Rindone, PharmD; Marjorie A. Ford, PharmD; David W. Jaskar, MD

Arch Intern Med. 1993;153(1):102-104.

Abstract
Background
Fluconazole has been reported to interact with many medications. This study examined the effect of low-dose fluconazole therapy on the hypoprothrombinemic response of warfarin sodium in patients.

Methods
Patients receiving low-intensity anticoagulation therapy with warfarin were recruited. All patients were taking stable doses of warfarin and had two baseline prothrombin times (PTs) within 10% of each other. Each patient received 100 mg of fluconazole daily for 7 days. Prothrombin times were measured on days 2,5, and 8 during fluconazole administration.

Results
All patients had a progressive increase in PTs. Mean (±SD) of PTs increased from 15.8±1 seconds before the administration of fluconazole to 18.9±1.9 seconds on day 5 and 21.9±2.2 seconds on day 8. Fluconazole therapy was stopped early in three patients due to high PTs. The largest change in PT was 9.7 seconds. No bleeding was noted during the study.

Conclusion: Fluconazole predictably potentiates the hypoprothrombinemic response of warfarin. Prothrombin times must be monitored when fluconazole is administered to patients taking warfarin.

(Arch Intern Med. 1993;153:102-104)

Author Affiliations
From the Pharmacy Service, Veterans Affairs Medical Center, Mountain Home, Tenn (Dr Crussell-Porter); Pharmacy Service, Veterans Affairs Medical Center and the the Departments of Pharmacy Practice (Dr Rindone) and Internal Medicine (Dr Jaskar), University of Arizona, Tucson; and the Pharmacy Service, Veterans Affairs Medical Center, Baltimore, Md (Dr Ford).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Interactions among Drugs for HIV and Opportunistic Infections
Piscitelli and Gallicano
NEJM 2001;344:984-996.
FULL TEXT  

Antipyrine as a Model Drug Substance to Assess Oxidative Metabolism
Konig and Cantilena
Arch Intern Med 1994;154:590-590.
ABSTRACT  

Antipyrine as a Model Drug Substance to Assess Oxidative Metabolism-Reply
Rindone
Arch Intern Med 1994;154:590-590.
ABSTRACT